Mega%252525252520cv

# Mega CV ## Overview Mega CV is a fixed-dose combination antibiotic containing **Amoxicillin** (a beta-lactam) and **Potassium Clavulanate** (a beta-lactamase inhibitor). The combination extends the spectrum of activity of amoxicillin to include beta-lactamase-producing organisms. ## Primary Indications Treatment of bacterial infections including acute bacterial sinusitis, community-acquired pneumonia, otitis media, skin and skin structure infections, and urinary tract infections caused by susceptible organisms. ## Adult Dosing * **Standard dosing:** 500 mg/125 mg orally every 8 or 12 hours. * **High-dose/More severe infections:** 875 mg/125 mg orally every 12 hours. * **Extended-release tablets:** 2000 mg/125 mg extended-release tablets every 12 hours. * *Note:* The 250 mg/125 mg tablet should not be used as a substitute for 875 mg/125 mg tablets due to equivalent clavulanate content leading to potential diarrhea. ## Pediatric Dosing Dosing is based on the amoxicillin component. * **Standard dose:** 20–45 mg/kg/day in divided doses every 8 to 12 hours. * **Maximum:** Follow specific weight-based pediatric guidelines; do not exceed adult maximums. * *Clarification:* Local institutional pediatric protocols often prefer specific mg/kg ratios to minimize the risk of diarrhea from excess clavulanate. Always verify via local formulary. ## Dose Adjustments * **Renal Impairment:** Reduce frequency in patients with CrCl <30 mL/min. Do not use the 875 mg tablet in patients with severe renal impairment (CrCl <30 mL/min). * **Hepatic Impairment:** Use with caution; monitor hepatic function periodically. ## Contraindications * History of serious hypersensitivity reactions (e.g., anaphylaxis) to amoxicillin or any penicillin. * History of cholestatic jaundice or hepatic dysfunction associated with previous use of amoxicillin/clavulanate. ## Adverse Effects * **Common:** Diarrhea (frequently associated with the clavulanate component), nausea, vomiting, skin rash, and candidiasis. * **Serious:** Clostridioides difficile-associated diarrhea (CDAD), hepatotoxicity (rare), severe cutaneous adverse reactions (SCARs), and anaphylaxis. ## Key Drug Interactions * **Probenecid:** Decreases renal tubular secretion of amoxicillin, increasing blood levels. * **Warfarin:** May increase INR/prothrombin time; monitor patients closely for bleeding. * **Oral Contraceptives:** May reduce efficacy; suggest backup contraception during therapy. * **Methotrexate:** May increase methotrexate toxicity. ## Monitoring * Monitor for signs of hypersensitivity (rash, urticaria, wheezing). * In prolonged therapy, assess renal, hepatic, and hematopoietic function. * Evaluate for persistent diarrhea (suspect *C. difficile*). ## Clinical Pearls * **Administration:** Take at the start of a meal to enhance absorption and reduce gastrointestinal side effects. * **Beta-lactamase:** Clavulanate is ineffective against many Gram-negative organisms producing extended-spectrum beta-lactamases (ESBLs); check local susceptibility patterns. * **Suspension:** Once reconstituted, oral suspensions typically require refrigeration and expire within 10 days. *** **Educational Disclaimer:** This information is for educational purposes only. Clinical practice guidelines and drug information evolve; always verify current prescribing information, institutional protocols, and patient-specific factors via the official package insert or standardized resources (e.g., Lexicomp, Micromedex) before prescribing or administering medication.